Loading...
Siemens Healthineers AG
SEMHF•PNK
Healthcare
Medical - Devices
$55.08
$-1.15(-2.05%)
Siemens Healthineers AG (SEMHF) Financial Performance & Statements
Review Siemens Healthineers AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.15%
↑ 3.15%
Operating Income Growth
29.002%
↑ 29.002%
Net Income Growth
28.69%
↑ 28.69%
Operating Cash Flow Growth
16.52%
↑ 16.52%
Operating Margin
13.72%
↑ 13.72%
Gross Margin
38.77%
↑ 38.77%
Net Profit Margin
9.03%
↑ 9.03%
ROE
11.16%
↑ 11.16%
ROIC
9.44%
↑ 9.44%
Siemens Healthineers AG (SEMHF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Siemens Healthineers AG stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.48B | $6.33B | $5.42B | $5.43B |
| Cost of Revenue | $3.33B | $3.92B | $3.33B | $3.43B |
| Gross Profit | $2.15B | $2.41B | $2.09B | $2.006B |
| Gross Profit Ratio | $0.39 | $0.38 | $0.39 | $0.37 |
| R&D Expenses | $481.00M | $496.00M | $484.00M | $474.00M |
| SG&A Expenses | $973.00M | $962.00M | $918.00M | $886.00M |
| Operating Expenses | $1.46B | $1.46B | $1.40B | $1.36B |
| Total Costs & Expenses | $4.79B | $5.38B | $4.74B | $4.79B |
| Interest Income | $31.00M | $29.00M | $27.00M | $32.00M |
| Interest Expense | $108.00M | $142.00M | $116.00M | $111.00M |
| Depreciation & Amortization | $305.00M | $309.00M | $295.00M | $328.00M |
| EBITDA | $1.03B | $1.29B | $1.006B | $916.00M |
| EBITDA Ratio | $0.19 | $0.20 | $0.19 | $0.17 |
| Operating Income | $697.00M | $950.00M | $688.00M | $646.00M |
| Operating Income Ratio | $0.13 | $0.15 | $0.13 | $0.12 |
| Other Income/Expenses (Net) | -$80.00M | -$106.00M | -$93.00M | -$104.00M |
| Income Before Tax | $617.00M | $844.00M | $595.00M | $542.00M |
| Income Before Tax Ratio | $0.11 | $0.13 | $0.11 | $0.10 |
| Income Tax Expense | $138.00M | $221.00M | $123.00M | $110.00M |
| Net Income | $474.00M | $616.00M | $469.00M | $426.00M |
| Net Income Ratio | $0.09 | $0.10 | $0.09 | $0.08 |
| EPS | $0.42 | $0.55 | $0.42 | $0.38 |
| Diluted EPS | $0.42 | $0.55 | $0.42 | $0.38 |
| Weighted Avg Shares Outstanding | $1.13B | $1.12B | $1.12B | $1.12B |
| Weighted Avg Shares Outstanding (Diluted) | $1.13B | $1.12B | $1.12B | $1.12B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan